Skip to content

Feasibility trial for people with musculoskeletal chest pain

Investigating a new approach to care for people with musculoskeletal chest pain: A randomised controlled feasibility trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000482561
Enrollment
26
Registered
2024-04-19
Start date
2024-04-22
Completion date
2024-06-07
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The overall aim of this research is to improve outcomes for people with musculoskeletal chest pain. We aim to contribute to an improved understanding of musculoskeletal chest pain and its management. This feasibility trial will assess the feasibility of conducting a full RCT comparing a new vs. current approach to care.

Interventions

New approach to care by a physiotherapist, in line with best practice. From the participant information sheet: Both groups will receive care from a physiotherapist that is in line with best practice. Participants will be asked to attend up to six sessions of 30-60 minutes over a six-week period, and one session at 12 weeks. If you are eligible and agree to participate in the study you will be allocated to a group, and the full details of the treatment sessions involved will be discussed with y

New approach to care by a physiotherapist, in line with best practice. From the participant information sheet: Both groups will receive care from a physiotherapist that is in line with best practice. Participants will be asked to attend up to six sessions of 30-60 minutes over a six-week period, and one session at 12 weeks. If you are eligible and agree to participate in the study you will be allocated to a group, and the full details of the treatment sessions involved will be discussed with you. The study design allows participants to be fully aware of the treatment involved in their own care, but unaware of the treatment involved in the other group. At the end of the 12 weeks, we will debrief you and explain the approach to care received by the other group, should you wish to explore this. All sessions will be done in the location where you join the study (School of Physiotherapy in Dunedin or Dunstan hospital in Clyde). Best practice is informed by a range of resources, including DynaMed. (2022). Costochondritis https://www.dynamed.com/condition/costochondritis

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Presents to ED with an acute episode of chest pain AND receives a primary diagnosis of suspected musculoskeletal chest pain • Age 16 years or over • History consistent with musculoskeletal causes (e.g., onset, activity- or position-dependent chest pain) • Evidence of musculoskeletal dysfunction on physical examination; (i.e., pain reproduction on palpation of sternocostal joint(s) or with deep breathing; pain reproduction and/or restriction with thoracic spine range of motion) • Able to provide informed consent • Able to speak and understand English

Exclusion criteria

• Non-mechanical, potentially serious sources of chest pain (e.g., cardiac, respiratory, infectious, systemic inflammatory, neoplastic processes, other priority non-musculoskeletal pain) as diagnosed by a medical practitioner. • Chronic overlapping pain conditions diagnosed by a medical practitioner as listed in the Central Sensitisation Inventory, Part B (e.g., restless leg syndrome, chronic fatigue syndrome, fibromyalgia, temporomandibular joint disorder, migraine or tension headaches, irritable bowel syndrome, multiple chemical sensitivities, neck injury (including whiplash), anxiety or panic attacks, depression (Mayer et al., 2012). • History of fractures or surgery to the chest and thoracic region (e.g., sternotomy), in the past six months. • Currently receiving treatment involving opioids and/or corticosteroids.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026